🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
154.68
-1.91 (-1.22%)
Nov 20, 2026, 10:20 AM EST - Market open

Neurocrine Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7022,8612,3551,8871,4891,134
Revenue Growth
37.98%21.45%24.81%26.76%31.34%8.38%
Cost of Revenue
1,3081,068765.1604.7487342.4
Gross Profit
2,3941,7931,5901,2821,002791.1
Selling, General & Admin
1,3601,156993.2887.6752.7583.3
Operating Expenses
1,4091,156993.2887.6752.7583.3
Operating Income
985.5636.5597394.8249207.8
Interest Expense
-3.2-----25.8
Interest & Investment Income
71.390.39152.84.13.8
EBT Excluding Unusual Items
1,054726.8688447.6253.1185.8
Gain (Loss) on Sale of Investments
-23.1-4-37.128.430.820.9
Gain (Loss) on Sale of Assets
28.6-----
Asset Writedown
---14---
Other Unusual Items
---138.4--70-
Pretax Income
932.1705.4486332.1213.9101.4
Income Tax Expense
229.6226.8144.782.459.411.8
Net Income
702.5478.6341.3249.7154.589.6
Net Income to Common
702.5478.6341.3249.7154.589.6
Net Income Growth
64.14%40.23%36.68%61.62%72.43%-78.00%
Shares Outstanding (Basic)
101100100989695
Shares Outstanding (Diluted)
1041031041019998
Shares Change
1.98%-1.16%2.67%2.12%1.02%0.10%
EPS (Basic)
6.974.813.402.561.610.95
EPS (Diluted)
6.734.673.292.471.560.92
EPS Growth
60.66%41.95%33.20%58.33%69.56%-77.89%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,040748.7557.2361.6322.9233.1
Free Cash Flow Per Share
9.987.305.373.583.272.38
Gross Margin
64.67%62.67%67.52%67.96%67.29%69.79%
Operating Margin
26.62%22.25%25.35%20.92%16.73%18.33%
Profit Margin
18.98%16.73%14.49%13.23%10.38%7.90%
Free Cash Flow Margin
28.09%26.17%23.66%19.16%21.69%20.57%
EBITDA
1,069666.6624.1416.1264.6218.7
EBITDA Margin
28.88%23.30%26.50%22.05%17.77%19.29%
D&A For EBITDA
83.630.127.121.315.610.9
EBIT
985.5636.5597394.8249207.8
EBIT Margin
26.62%22.25%25.35%20.92%16.73%18.33%
Effective Tax Rate
24.63%32.15%29.77%24.81%27.77%11.64%
Revenue as Reported
3,7022,8612,3551,8871,4891,134
Advertising Expenses
-226.8191159.9149.7139.8
SEC Filings: 10-K · 10-Q